Paper923734
Mitogenic action of neuraminidase.
Semenzato G and 3 others. Experientia, 1977. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mitogenic action of neuraminidase. Papers, record 923734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/923734
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphocyte Activation | Major topic |
| Mitogens | Major topic |
| Neuraminidase | Major topic |
| Humans | |
| Vibrio cholerae |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4357270 | Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. | Blood | 1973 | https://conductscience.org/library/papers/4357270 | PubMed |
| 2 | 4469229 | Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients. | Clin Exp Immunol | 1974 | https://conductscience.org/library/papers/4469229 | PubMed |
| 3 | 4162339 | Mitogenic action of papain. | Lancet | 1966 | https://conductscience.org/library/papers/4162339 | PubMed |
| 4 | 984732 | [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)]. | Ann Immunol (Paris) | 1976 | https://conductscience.org/library/papers/984732 | PubMed |
| 5 | 4138857 | Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974. | Scand J Immunol | 1974 | https://conductscience.org/library/papers/4138857 | PubMed |
| 6 | 4161182 | Mitogenic action of trypsin and chymotrypsin. | Lancet | 1966 | https://conductscience.org/library/papers/4161182 | PubMed |
| 7 | 1254945 | Transformation of human peripheral lymphocytes by galactose oxidase. | J Immunol | 1976 | https://conductscience.org/library/papers/1254945 | PubMed |
| 8 | 4122710 | Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. | J Exp Med | 1973 | https://conductscience.org/library/papers/4122710 | PubMed |
| 9 | 5042921 | The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity. | Clin Exp Immunol | 1972 | https://conductscience.org/library/papers/5042921 | PubMed |
| 10 | 4352200 | Neuraminidase "unmasking" and failure of trypsin to "unmask" -D-galactose-like sites on erythrocyte, lymphoma, and normal and virus-transformed fibroblast cell membranes. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4352200 | PubMed |
| 11 | 4517665 | Transformation of neuraminidase-treated lymphocytes by soybean agglutinin. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4517665 | PubMed |
| 12 | 4818458 | The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. | J Immunol | 1974 | https://conductscience.org/library/papers/4818458 | PubMed |
| 13 | 4404957 | The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase. | Transplantation | 1972 | https://conductscience.org/library/papers/4404957 | PubMed |
| 14 | 4765377 | Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4765377 | PubMed |
| 15 | 5062405 | Stimulation of DNA synthesis in mammalian cell cultures by receptor-destroying enzyme and neuraminidase. | Anat Rec | 1972 | https://conductscience.org/library/papers/5062405 | PubMed |
| 16 | 4110358 | Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. | Clin Exp Immunol | 1971 | https://conductscience.org/library/papers/4110358 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6966605 | Enhancement of T-cell response to PWM by neuraminidase-treated non-T cells. | Immunology | 1980 | https://conductscience.org/library/papers/6966605 | PubMed |
| 431030 | [Glycoproteins: their biological and clinical significance. II (author's transl)]. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/431030 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NEU1 | 4758 | PubTator's text mining | https://conductscience.org/library/genes/4758 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/923734
GET https://conductscience.org/api/papers/v1/923734/authors